Mirna Recommended for $10.3M Texas Grant, Poised to Close $25M Series B

The money is expected to help Mirna meet its goal of filing two INDs by the end of 2011 as it adds staffers to support its drug-development efforts and seeks industry partnerships, according to a company official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.